跳至主要内容
临床试验/NCT01696630
NCT01696630已完成2 期

Phase II Study, Randomized, Monocentric, Single-blind, Comparing the Efficacy of Xenon and Desflurane, in Association With a Thoracic Epidural Analgesia in the Maintenance Phase of a Colorectal Oncologic Surgery

Centre Leon Berard1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2012年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
31
试验地点
1
主要终点
Variation of intraoperative Mean Arterial Pressure (MAP)

研究概览

简要总结

This is a monocentric study in 2 steps: A safety part to assess the feasibility of using Xenon in association with a thoracic epidural analgesia (TEA) with a sequential recruitment of 3, 6 or 9 patients according to predefined safety rules. The second part will randomly allocated patients (1:1) to receive TEA+Xenon or TEA+Desflurane. 28 patients will be enrolled and followed over 45 days.

详细描述

The first step is divided into 3 parts. 9 patients will be sequentially enrolled (3 patients in each part). The patients will be followed during 45 days and the following rules will be used to assess the safety:

First part: if no toxicity: initiation of the randomised part. If 1/3 toxicity: start of the second part. If 2 or 3/3 toxicity: end of the study.

Second part: same rules and possible start of the third part. Third part: if no toxicity: initiation of the randomised part. If 1 or more toxicity: end of the study.

The safety will be assessed after each part by an independent data safety monitoring board.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Older than 18 years old
  • Planned surgery for oncologic colic and/or rectal surgery
  • ASA score I or II
  • Indication of complementary thoracic epidural analgesia
  • Agree to use an effective form of contraception
  • Patients who can understand, read and write French language
  • Covered by a medical insurance
  • Patients who have dated/signed an inform consent

排除标准

  • Unstable angina within the 30 last days
  • Myocardial infarction within 28 days prior to surgery
  • Uncontrolled arterial high blood pressure
  • Severe cardiac insufficiency
  • Severe chronic obstructive pneumopathy
  • Patient who requires FiO2 > 40%
  • Patient already enrolled in a clinical study which may interfere with the present study
  • Known hypersensitivity to one of the study drugs
  • History or familial history of malignant hyperthermia
  • Documented high intracranial pressure
  • Eclampsia or pre-eclampsia
  • Pregnant or breastfeeding woman
  • Liver injury (icterus) and/or unexplained fever and/or eosinophilia after halogen exposure
  • Failure in epidural anesthesia installation
  • Patient refusal
  • Patient who can't be compliant to the present protocol

研究组 & 干预措施

Desflurane

Active Comparator

Desflurane 6.5% (+/-0.5%) in association with a thoracic epidural analgesia in maintenance phase

干预措施: Desflurane (Drug)

Xenon

Experimental

Xenon 60% (+/-5%) in association with a thoracic epidural analgesia in maintenance phase

干预措施: Xenon (Drug)

结局指标

主要结局

Variation of intraoperative Mean Arterial Pressure (MAP)

时间窗: Maintenance phase

Variation between the Mean Arterial Pressure (MAP) at induction and the mean of intraoperative MAP values in each patient and comparaison between arms.

次要结局

  • Measure of hemodynamic parameters (Systolic Ejection Volume, Heart rate, DeltaPP)(Throughout the maintenance of anesthesia, an expected average of 6 hours)
  • Delay from the surgery to the discharge date(from the surgery to the hospital discharge date)
  • Delay between the end of surgery and Post Anesthesia Care Unit's exit (min)(from the end of surgery up to Post Anesthesia Care Unit's exit)
  • Total dose requirement of Vasopressive and hypotensive agents(Throughout the maintenance of anesthesia, an expected average of 6 hours)
  • Volume of each product infused(Throughout the maintenance of anesthesia, an expected average of 6 hours)
  • Total dose of morphine(Throughout the maintenance of anesthesia, an expected average of 6 hours)
  • Quality of awaking(5 minutes after eyes opening)
  • Delay to oral feeding recovery(From surgery to oral feeding reintroduction)
  • Post-operative Adverse Events(45 days after surgery)
  • post-operative pain(At entrance and exit of post operative room and 24 hours after the end of anesthesia)
  • Delay to intestinal transit recovery(Time to postoperative stools)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验